Skip to main content

Advertisement

Log in

Neurosarcoidosis Presenting as a Cerebellar Mass

  • Case Reports/Clinical Vignettes
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

CASE REPORT

A 74-year-old farmer presented with worsening headaches, gait unsteadiness, and writing difficulties. On examination, he had a tendency to fall to the right and right-sided dysmetria and dysdiadochokinesis. Magnetic resonance imaging initially showed abnormalities in the right cerebellar hemisphere, suggestive of subacute infarct or infiltrating malignancy. Suboccipital craniotomy and biopsy revealed noncaseating granulomas suggestive of sarcoidosis. He was initially treated with steroids and later switched to Infliximab. On follow-up 5 months later, symptoms and imaging had improved.

DISCUSSION

Sarcoidosis affects the central nervous system in about 5% of patients. It usually manifests with cranial nerve palsies. It may rarely mimic a tumor as in this patient. Despite the dearth of controlled studies addressing neurosarcoidosis treatment, excellent responses to corticosteroids have been documented. Infliximab has been used as a steroid-sparing agent in neurosarcoidosis. We present this case of neurosarcoidosis presenting as a cerebellar mass to increase awareness of this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Boeck C. Multiple benign sarcoid of the skin. J Cutan Genito-Urin Dis. 1899;17:543–50.

    Google Scholar 

  2. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909–17.

    PubMed  CAS  Google Scholar 

  3. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977;87:336–45.

    PubMed  CAS  Google Scholar 

  4. Kidd D, Beynon HL. The neurological complications of systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:85–94.

    PubMed  Google Scholar 

  5. Mirfakhraee M, Crofford MJ, Guinto FC, Nauta HJ, Weedn VW. Virchow–Robin space: a path of spread in neurosarcoidosis. Radiology. 1986;158:715–20.

    PubMed  CAS  Google Scholar 

  6. Mana J. Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr Opin Pulm Med. 2002;8(5):457–63.

    Article  PubMed  Google Scholar 

  7. Wiesli P, Hess K, Cathomas G, Stey C. Neurosarcoidosis presenting as cerebellar mass. Eur Neurol. 2000;43(1):58–9.

    Article  PubMed  CAS  Google Scholar 

  8. Oksanen V. Neurosarcoidosis: clinical presentation and course in 50 patients. Acta Neurol Scand. 1986;73:283–90.

    Article  PubMed  CAS  Google Scholar 

  9. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax. 1999;54:742–6.

    Article  PubMed  CAS  Google Scholar 

  10. Stern BJ, Schonfeld SA, Sewell C, Krumholz A, Scott P, Belendiuk G. The treatment of neurosarcoidosis with cyclosporine. Arch Neurol. 1991;49:1065–72.

    Google Scholar 

  11. Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest. 2003;124:2023–6.

    Article  PubMed  Google Scholar 

  12. Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol. 1998;55:1248–54.

    Article  PubMed  CAS  Google Scholar 

  13. Baughman RP. Therapeutic options for sarcoidosis: new and old. Curr Opin Pulm Med. 2002;8:464–9.

    Article  PubMed  Google Scholar 

  14. Sollberger M, Fluri F, Baumann T, et al. Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol. 2004;251(6):760–1.

    Article  PubMed  CAS  Google Scholar 

  15. Carter JD, Valeriano J, Vasey FB, Bognar B. Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med. 2004;117(4):277–9.

    Article  PubMed  Google Scholar 

  16. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 2005;127(3):1064–71.

    Article  PubMed  CAS  Google Scholar 

  17. Browne SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. 2002;46(12):3151–8.

    Article  CAS  Google Scholar 

  18. Foley KT, Howell JD, Junck L. Progression of hydrocephalus during corticosteroid therapy for neurosarcoidosis. Postgrad Med J. 1989;65:481–4.

    Article  PubMed  CAS  Google Scholar 

  19. Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol. 2004;17:311–6.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Conflict of Interest

None disclosed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gautam Kumar MBBS, MRCP(UK).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, G., Kang, C.A. & Giannini, C. Neurosarcoidosis Presenting as a Cerebellar Mass. J GEN INTERN MED 22, 1373–1376 (2007). https://doi.org/10.1007/s11606-007-0272-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-007-0272-7

KEY WORDS

Navigation